FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Comments Sought on Consumer Risk/Benefit Surveys

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on the national consumer surveys that assess public understanding of the risks and ben...

Comments Sought on Patent Term Regulations

[ Price : $8.95]

Federal Register Notice: Federal Register Notice: FDA seeks comments on patent term restoration regulations on due diligence petit...

Comments Sought on Communications Studies of Biological Products

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on communications studies about FDA-regulated biological products.

Hearing on Biologics Price Competition and Innovation Act

[ Price : $8.95]

Federal Register Notice: FDA will hold a public hearing 11/2-3 on implementing the Biologics Price Competition and Innovation Act ...

Modifications to Device Standards Published

[ Price : $8.95]

Federal Register Notice: FDA releases its modifications to the list of recognized consensus standards for use in premarket device ...

FDA Clears Orthovita Dental Bone Grafting Material

[ Price : $8.95]

Orthovita, Inc. receives FDA 510(k) clearance to market its Vitomatrix Bone Graft Substitute as bone grafting material for use in ...

FDA Faulted on Orphan Drug Development

[ Price : $8.95]

A new Institute of Medicine report on orphan drugs makes a number of recommendations for changes in CDER and CDRH activities.

Google Pushes Drug Companies to Test Ads

[ Price : $8.95]

Google wants drug marketers to test an online ad format using a drugs name, indications, and risk information.

FDA Quietly Posts 'Strategic Priorities' Draft

[ Price : $8.95]

An unheralded draft strategic priorities document lays out FDA's priorities for the next five years advancing regulatory science,...

FDA Grant Awards for TB Research

[ Price : $8.95]

FDA awards $2.9 million to support six research projects on tuberculosis diagnosis, treatment, and prevention.